Clinical effectiveness and safety of a new NSAID, firocoxib: a 1,000 dog study.

@article{Ryan2006ClinicalEA,
  title={Clinical effectiveness and safety of a new NSAID, firocoxib: a 1,000 dog study.},
  author={William G. Ryan and Katherine Moldave and Doug S. Carithers},
  journal={Veterinary therapeutics : research in applied veterinary medicine},
  year={2006},
  volume={7 2},
  pages={119-26}
}
For the Previcox (firocoxib, Merial) Experience Trial, practicing veterinarians across the United States were asked to enroll dogs diagnosed with osteoarthritis (OA). At an initial visit, owners of dogs deemed suitable for NSAID therapy were given Previcox and instructed to maintain a daily diary and to return 10 and 40 days after treatment began. Approximately 86% of the 1,002 enrolled dogs completed the study. The withdrawal rate associated with gastrointestinal side effects was low (2.9% of… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

Similar Papers

Loading similar papers…